- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics | 1 | Benzinga.com | ||
| Fr | William Blair initiates Beta Bionics stock rating at Market Perform | 2 | Investing.com | ||
| 30.07. | Beta Bionics outlines Mint launch by end of Q2 2027 while raising 2026 gross margin outlook to 58.5%-59.5% | 2 | Seeking Alpha | ||
| 29.07. | Beta Bionics Q2 2026 slides: revenue hits $32M, margins reach 59% | 3 | Investing.com | ||
| 29.07. | Beta Bionics, Inc. (BBNX) Reports Q2 Loss, Tops Revenue Estimates | 1 | Zacks | ||
| BETA BIONICS Aktie jetzt für 0€ handeln | |||||
| 29.07. | Beta Bionics, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 29.07. | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | 433 | GlobeNewswire (Europe) | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| 01.07. | Beta Bionics, Inc.: Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026 | 6 | GlobeNewswire (USA) | ||
| 02.06. | Beta Bionics launches real-time data dashboard for iLet device | 2 | Investing.com | ||
| 02.06. | Beta Bionics, Inc.: Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website | 1 | GlobeNewswire (USA) | ||
| 21.05. | Beta Bionics earmarks Q2 2027 for Mint patch pump launch, shares details on new tech | 1 | MassDevice | ||
| 21.05. | Beta Bionics, Inc.: Beta Bionics Updates Commercialization Timeline Expectations for Mint, its Patch Pump in Development | 2 | GlobeNewswire (USA) | ||
| 21.05. | Beta Bionics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.04. | Beta Bionics: Lake Street bekräftigt "Buy" nach übertroffenen Q1-Erwartungen | 1 | Investing.com Deutsch | ||
| 22.04. | Lake Street reiterates Buy on Beta Bionics stock on Q1 beat | 1 | Investing.com | ||
| 22.04. | Piper Sandler cuts Beta Bionics stock price target on valuation | 1 | Investing.com | ||
| 22.04. | Stifel cuts Beta Bionics stock price target on opex ramp concerns | 3 | Investing.com | ||
| 22.04. | Stifel senkt Kursziel für Beta Bionics wegen Sorgen um steigende Betriebskosten | 1 | Investing.com Deutsch | ||
| 22.04. | Wolfe Research cuts Beta Bionics stock price target on guidance | 1 | Investing.com | ||
| 22.04. | Beta Bionics projects $131M-$136M 2026 revenue and raises gross margin outlook to 57.5%-59.5% | 3 | Seeking Alpha |
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,600 | +0,83 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen Euro | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen... ► Artikel lesen | |
| VIROMED MEDICAL | 7,250 | +1,40 % | Viromed Medical: Innovativer Durchbruch in der Gesundheitsbranche sorgt für Aufsehen | ||
| FRESENIUS MEDICAL CARE | 40,140 | -1,83 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,200 | +0,98 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| HEARTFLOW | 49,750 | 0,00 % | Heartflow Aktie auf Rekordhoch: Kurs steigt auf 48,7 USD | ||
| LIFESTANCE HEALTH GROUP | 12,470 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 13,170 | +0,08 % | Aveanna Healthcare (AVAH) Just Ended A Four-Year Rate Fight | ||
| PROGYNY | 25,650 | 0,00 % | Progyny, Inc. Announces Second Quarter 2026 Results | Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDARobust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building SolutionsValue Returned to Shareholders... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,84 | -0,05 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BILLIONTOONE | 95,20 | +0,18 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,480 | +1,06 % | Milliardenmarkt Augengesundheit: Warum EssilorLuxottica und Carl Zeiss Meditec auf neue Technologien setzen - und wo Rise Nano Optics ins Spiel kommt | ||
| GENEDX | 87,05 | 0,00 % | GeneDx launches online exome testing for pediatric patients | ||
| ALIGNMENT HEALTHCARE | 13,165 | +0,04 % | Alignment Healthcare files motion to dismiss whistleblower lawsuit | ||
| SANARA MEDTECH | 34,430 | -0,06 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,120 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |
BETA BIONICS INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 19,040 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BETA BIONICS INC finden Sie auf Wallstreet Online.